Catalysts, Volume 12, Issue 12
2022 December - 188 articles
Cover Story: With the increase in biodiesel production in recent years, excess production of glycerol is a reality. Glycerol is now a platform chemical that can be transformed into various chemical intermediates, including prodrugs of NSAIDs such as ibuprofen, reducing the adverse effects of their chronic administration. Their production by mild esterification with lipases is a possibility, while the development of continuous or flow processes based on multiphase systems in the pharma industry is key for process intensification and product quality. For the first time, we show that the appropriate selection of cosolvents such as glycerol, toluene, and water and of process conditions leads to high stability and activity of the commercial preparation Novozym®435, an immobilised biocatalyst based on lipase B from Candida antarctica. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.